Physician profile
Jonathan C Rainer
NPI 1336274810
$4,470.44
in general payments reported to CMS, 2019-2025
38 companies · $505 in 2025
The $505 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $594 · 2021: $755 · 2022: $510 · 2023: $406 · 2024: $301 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,251.00 | 2020-2025 | |
| Allergan, INC. | $528.79 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $363.61 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $219.45 | 2020-2025 | Relistor |
| Teva Pharmaceuticals USA, INC. | $197.96 | 2019 | |
| Adamas Pharmaceuticals, INC. | $187.90 | 2019-2021 | |
| Pacira Therapeutics, INC. | $172.93 | 2019-2021 | |
| Ucb, INC. | $128.80 | 2019-2022 | |
| Sk Life Science, INC. | $128.58 | 2021-2022 | |
| Lilly USA, LLC | $124.55 | 2019-2023 | Amyvid |
| Zyla Life Sciences, INC. | $113.76 | 2019-2020 | |
| Tanabe Pharma America, INC. | $104.93 | 2019-2022 | |
| Lundbeck LLC | $96.79 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $88.61 | 2019-2021 | |
| Nevro Corp. | $86.31 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $73.86 | 2019 | |
| Amgen INC. | $69.50 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $62.02 | 2019-2023 | |
| Globus Medical, INC. | $43.97 | 2025 | Senza |
| Medtronic, INC. | $42.30 | 2021-2024 | Intellis Adaptivestim |
| Biogen, INC. | $41.14 | 2020-2022 | |
| Avanos Medical | $39.00 | 2019 | |
| Tersera Therapeutics LLC | $36.54 | 2019 | |
| Vertical Pharmaceuticals, LLC | $27.03 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $24.83 | 2019 | |
| Grifols USA, LLC | $24.14 | 2023 | Gamunex-C |
| Depuy Synthes Sales INC. | $22.69 | 2024 | Orthovisc, Monovisc |
| Upsher-Smith Laboratories LLC | $22.67 | 2021 | |
| Abbott Laboratories | $21.98 | 2022 | |
| Stryker Corporation | $19.72 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $18.64 | 2024 | |
| Ani Pharmaceuticals, INC. | $15.53 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.54 | 2021 | |
| Currax Pharmaceuticals LLC | $12.17 | 2022 | |
| Flowonix Medical Incorporated | $11.40 | 2019 | |
| Bioventus LLC | $11.36 | 2020 | |
| Pfizer INC. | $10.90 | 2019 | |
| Grt US Holding, INC. | $10.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rainer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.